In particular, KEAP1 and NRF2 mutations are encountered in 20–30% of non-small cell lung cancers (Cancer Genome Atlas Research Network 2012; Imielinski et al. 2012; Cancer Genome Atlas Research Network 2014; Campbell et al. 2016). The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.